<DOC>
	<DOCNO>NCT00919880</DOCNO>
	<brief_summary>The purpose study determine whether neo-adjuvant weekly paclitaxel carboplatin well paclitaxel alone efficiency safety early breast cancer , explore whether ultrasound magnetic resonance image predict efficiency neo-adjuvant chemotherapy .</brief_summary>
	<brief_title>Comparison Neo-adjuvant Weekly Paclitaxel With Without Carboplatin Early Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>female patient 18 65 year old pathological diagnose invasive breast cancer ; medium high risk primary breast cancer accord St. Gallen 2007 able willing give consent participate study pregnant lactating female previous treatment breast cancer tumor history instable complication ( e.g. , myocardial infarction within 6 month , arrhythmia , unstable diabetes , hypercalcemia ) uncontrolled infection allergy history similar drug concurrent disease condition would make patient inappropriate study participation resist participate study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>